Barclays PLC reiterated their equal weight rating on shares of Ambev S.A. (NYSE:ABEV) in a research report sent to investors on Saturday morning, StockTargetPrices.com reports.
A number of other research firms have also weighed in on ABEV. Zacks Investment Research lowered shares of Ambev from a buy rating to a hold rating in a research note on Monday, July 31st. BidaskClub lowered shares of Ambev from a strong-buy rating to a buy rating in a research note on Thursday, September 28th. Evercore ISI reissued an outperform rating and issued a $8.50 target price (up from $7.00) on shares of Ambev in a research note on Friday, October 13th. Finally, Credit Suisse Group upgraded shares of Ambev from a neutral rating to an outperform rating in a report on Tuesday, September 12th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and three have assigned a buy rating to the company’s stock. The stock presently has an average rating of Hold and an average target price of $7.28.
Ambev (NYSE:ABEV) opened at 6.33 on Friday. Ambev has a 1-year low of $4.70 and a 1-year high of $7.03. The stock’s 50 day moving average price is $6.67 and its 200-day moving average price is $6.08. The company has a market cap of $99.43 billion, a PE ratio of 27.40 and a beta of 0.66.
WARNING: This article was first published by Community Financial News and is the property of of Community Financial News. If you are accessing this article on another website, it was illegally copied and reposted in violation of U.S. and international trademark & copyright legislation. The correct version of this article can be viewed at https://www.com-unik.info/2017/11/01/barclays-plc-reiterates-equal-weight-rating-for-ambev-s-a-abev.html.
Several hedge funds and other institutional investors have recently made changes to their positions in the company. Raymond James Financial Services Advisors Inc. increased its holdings in shares of Ambev by 1.0% during the 2nd quarter. Raymond James Financial Services Advisors Inc. now owns 40,090 shares of the company’s stock worth $220,000 after buying an additional 381 shares during the last quarter. Advisory Services Network LLC increased its holdings in Ambev by 1.0% in the 2nd quarter. Advisory Services Network LLC now owns 179,401 shares of the company’s stock valued at $985,000 after purchasing an additional 1,700 shares during the last quarter. Telemus Capital LLC increased its holdings in Ambev by 2.6% in the 2nd quarter. Telemus Capital LLC now owns 69,234 shares of the company’s stock valued at $380,000 after purchasing an additional 1,729 shares during the last quarter. Earnest Partners LLC increased its holdings in Ambev by 4.3% in the 2nd quarter. Earnest Partners LLC now owns 47,802 shares of the company’s stock valued at $262,000 after purchasing an additional 1,956 shares during the last quarter. Finally, Cambridge Investment Research Advisors Inc. increased its holdings in Ambev by 6.1% in the 2nd quarter. Cambridge Investment Research Advisors Inc. now owns 34,318 shares of the company’s stock valued at $188,000 after purchasing an additional 1,971 shares during the last quarter. Institutional investors and hedge funds own 7.32% of the company’s stock.
Ambev Company Profile
Ambev SA, formerly Inbev Participacoes Societarias SA, is a Brazil-based company engaged in the brewing sector. The Company produces and sells beer, carbonated soft drinks (CSDs) and other non-alcoholic and non-carbonated (NANC) beverages across the Americas. The Company’s activities are divided into three segments: Latin America North, including sell of beer, CSD and NANC drinks in Brazil, as well as operations in Dominican Republic, Saint Vincent, Antigua, Dominica, Guatemala, El Salvador, Nicaragua and Cuba; Latin America South, distributing products in Argentina, Bolivia, Paraguay, Uruguay, Chile, Ecuador, Peru and Colombia, and Canada, represented by Labatt’s operations, which comprises sales in Canada.
What are top analysts saying about Ambev S.A.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Ambev S.A. and related companies.